Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1
Closed -$4 3277
2022
Q4
$4 Sell
1
-165
-99% -$937 ﹤0.01% 3837
2022
Q3
$1K Buy
166
+138
+493% +$1.05K ﹤0.01% 3801
2022
Q2
$0 Sell
28
-71,834
-100% -$628K ﹤0.01% 3901
2022
Q1
$910K Sell
71,862
-6,940
-9% -$76.5K ﹤0.01% 2599
2021
Q4
$969K Buy
+78,802
New +$1.39M ﹤0.01% 3340

Other funds holding AMTX

Credit Suisse's AMTX Position: Q1 2023 in Review

Credit Suisse sold out of Aemetis (AMTX) in Q1 2023, closing a stake of 1 share — an estimated $4 sold.

Credit Suisse first reported a position in AMTX in Q4 2021 and held it in 5 quarters. The position peaked at $969K in Q4 2021. 77 funds tracked by Wall St. Rank hold AMTX as of Q1 2023.

  • Credit Suisse reported no remaining Aemetis position as of Q1 2023 after selling out during the quarter.
  • Credit Suisse sold 1 Aemetis share in Q1 2023, an estimated $4.
  • Credit Suisse first reported a position in Aemetis in Q4 2021 and held it in 5 quarters.
  • Credit Suisse's Aemetis position peaked at $969K in Q4 2021.
  • 77 funds tracked by Wall St. Rank held Aemetis as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.